159 related articles for article (PubMed ID: 36249820)
21. Cyp4a12-mediated retinol metabolism in stellate cells is the antihepatic fibrosis mechanism of the Chinese medicine Fuzheng Huayu recipe.
Ping DB; Sun X; Peng Y; Liu CH
Chin Med; 2023 May; 18(1):51. PubMed ID: 37161575
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and Safety of a Botanical Formula Fuzheng Huayu for Hepatic Fibrosis in Patients with CHC: Results of a Phase 2 Clinical Trial.
Hassanein T; Tai D; Liu C; Box TD; Tong MJ; Rossaro L; Pozza R; Glenn JS; Cheung R; Hemaidan A; He Y; Behling C; Hu X; Makhlouf H; Fan H; Ren Y; Khim Chng EL; Liu P; Vierling JM
Evid Based Complement Alternat Med; 2022; 2022():4494099. PubMed ID: 35873630
[TBL] [Abstract][Full Text] [Related]
23. The Active Components of Fuzheng Huayu Formula and Their Potential Mechanism of Action in Inhibiting the Hepatic Stellate Cells Viability - A Network Pharmacology and Transcriptomics Approach.
Xing X; Chen S; Li L; Cao Y; Chen L; Wang X; Zhu Z
Front Pharmacol; 2018; 9():525. PubMed ID: 29881350
[No Abstract] [Full Text] [Related]
24. Pharmacological mechanisms of Fuzheng Huayu formula for Aristolochic acid I-induced kidney fibrosis through network pharmacology.
Wang F; Wang S; Wang J; Huang K; Chen G; Peng Y; Liu C; Tao Y
Front Pharmacol; 2022; 13():1056865. PubMed ID: 36569327
[TBL] [Abstract][Full Text] [Related]
25. Fuzheng Huayu Capsule Attenuates Hepatic Fibrosis by Inhibiting Activation of Hepatic Stellate Cells.
Wu M; Zhou Y; Qin SL; Lin LJ; Ping J; Tao Z; Zhang J; Xu LM; Wu J
Evid Based Complement Alternat Med; 2020; 2020():3468791. PubMed ID: 32454856
[TBL] [Abstract][Full Text] [Related]
26. The Novel Chinese Medicine JY5 Formula Alleviates Hepatic Fibrosis by Inhibiting the Notch Signaling Pathway.
Fu Y; Xiao Z; Tian X; Liu W; Xu Z; Yang T; Hu Y; Zhou X; Fang J; Gao S; Zhang D; Mu Y; Zhang H; Hu Y; Huang C; Chen J; Liu P
Front Pharmacol; 2021; 12():671152. PubMed ID: 34630075
[TBL] [Abstract][Full Text] [Related]
27. Effect of Fuzheng Huayu formula and its actions against liver fibrosis.
Liu C; Hu Y; Xu L; Liu C; Liu P
Chin Med; 2009 Jun; 4():12. PubMed ID: 19558726
[TBL] [Abstract][Full Text] [Related]
28. Proteomic analysis of the effect of fuzheng huayu recipe on fibrotic liver in rats.
Xie H; Tao Y; Lv J; Liu P; Liu C
Evid Based Complement Alternat Med; 2013; 2013():972863. PubMed ID: 23431353
[TBL] [Abstract][Full Text] [Related]
29. An Herbal Product Alleviates Bleomycin-Induced Pulmonary Fibrosis in Mice via Regulating NF-κB/TNF-α Signaling in Macrophages.
Jing F; Chen X; Xue J; Huang K; Xing F; Hu X; Peng Y; Liu C
Front Pharmacol; 2022; 13():805432. PubMed ID: 35548340
[No Abstract] [Full Text] [Related]
30. [Effects of Fuzheng Huayu recipe on MMP-2 activity and type IV collagen expression at fibrotic lung].
Tan SZ; Liu CH; Zhang W; Lu X; Ye WC; Cai ZZ; Liu P
Zhongguo Zhong Yao Za Zhi; 2007 May; 32(9):835-9. PubMed ID: 17639988
[TBL] [Abstract][Full Text] [Related]
31. Modulation of IKKβ/NF-κB and TGF-β1/Smad via Fuzheng Huayu recipe involves in prevention of nutritional steatohepatitis and fibrosis in mice.
Wang RQ; Mi HM; Li H; Zhao SX; Jia YH; Nan YM
Iran J Basic Med Sci; 2015 Apr; 18(4):404-11. PubMed ID: 26019805
[TBL] [Abstract][Full Text] [Related]
32. Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV)
Ge FL; Si LL; Yang Y; Li YH; Lv ZL; Liu WH; Liao H; Wang J; Zou J; Li L; Li H; Zhang ZL; Wang JB; Lu XC; Xu DP; Bai ZF; Liu Y; Xiao XH
Front Pharmacol; 2021; 12():756975. PubMed ID: 34776974
[TBL] [Abstract][Full Text] [Related]
33. Regulation of Fuzheng Huayu capsule on inhibiting the fibrosis-associated hepatocellular carcinogenesis.
Zhang WQ; Sun JX; Lan ST; Sun XM; Guo YJ; Wen BC; Chen J; Liu G
J Asian Nat Prod Res; 2024 May; ():1-20. PubMed ID: 38780602
[TBL] [Abstract][Full Text] [Related]
34. Dynamical Regulation Analysis Identifies Molecular Mechanisms of Fuzheng-Huayu Formula against Hepatitis B-Caused Liver Cirrhosis.
Chen QL; Lu YY; Peng JH; Dong S; Wei B; Song YN; Zhou QM; Zhang H; Liu P; Su SB
Evid Based Complement Alternat Med; 2015; 2015():238495. PubMed ID: 26221171
[TBL] [Abstract][Full Text] [Related]
35. Fuzheng Huayu recipe and vitamin E reverse renal interstitial fibrosis through counteracting TGF-beta1-induced epithelial-to-mesenchymal transition.
Wang QL; Yuan JL; Tao YY; Zhang Y; Liu P; Liu CH
J Ethnopharmacol; 2010 Feb; 127(3):631-40. PubMed ID: 20015471
[TBL] [Abstract][Full Text] [Related]
36. Histological Outcome of Fuzheng Huayu plus Entecavir Combination Therapy in Chronic Hepatitis B Patients with Significant Liver Fibrosis.
Gui HL; Zhao CQ; Wang Y; Gu HT; Wang WJ; Cai W; Guo Q; Bao SS; Xu LM; Xie Q
J Clin Transl Hepatol; 2020 Sep; 8(3):277-284. PubMed ID: 33083250
[No Abstract] [Full Text] [Related]
37. Baicalin benefits the anti-HBV therapy via inhibiting HBV viral RNAs.
Huang H; Zhou W; Zhu H; Zhou P; Shi X
Toxicol Appl Pharmacol; 2017 May; 323():36-43. PubMed ID: 28322895
[TBL] [Abstract][Full Text] [Related]
38. Chinese herbal formula Fuzheng Huayu alleviates CCl
Dong S; Cai FF; Chen QL; Song YN; Sun Y; Wei B; Li XY; Hu YY; Liu P; Su SB
Acta Pharmacol Sin; 2018 Jun; 39(6):930-941. PubMed ID: 29094729
[TBL] [Abstract][Full Text] [Related]
39. Fuzheng Huayu Formula () prevents rat renal interstitial fibrosis induced by HgCl
Yuan JL; Tao YY; Wang QL; Shen L; Liu CH
Chin J Integr Med; 2017 Aug; 23(8):598-604. PubMed ID: 28197934
[TBL] [Abstract][Full Text] [Related]
40. Comparative pharmacokinetics and tissue distribution profiles of lignan components in normal and hepatic fibrosis rats after oral administration of Fuzheng Huayu recipe.
Yang T; Liu S; Zheng TH; Tao YY; Liu CH
J Ethnopharmacol; 2015 May; 166():305-12. PubMed ID: 25794805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
